Symptom/Sign/Lab test | BD group, No. positive (percent) | Non-BD group, No. positive (percent) | P-value |
---|---|---|---|
Oral lesions | 40 (100%) | 83 (89.25%) | 0.031 |
Genital lesions | 26 (65%) | 17 (18.28%) | < 0.001 |
Ocular lesions | 20 (50%) | 13 (13.98%) | < 0.001 |
Erythema Nodosum | 11 (27.5%) | 0 (0%) | < 0.001 |
Articular involvement | 10 (25%) | 13 (14%) | 0.123 |
Pseudofolliculitis | 3 (7.5%) | 0 (0%) | 0.008 |
Gastrointestinal | 3 (7.5%) | 12 (12.9%) | 0.18 |
Cardiovascular | 2 (5%) | 2 (2.1%) | 0.51 |
Neurologic involvement | 1 (2.5%) | 2 (2.1%) | 0.9 |
Positive Pathergy reaction | 18 (45%) | 0 | < 0.001 |
Leukocyte antigens | |||
HLA-B5 | 26 (65%) | 46 (49%) | 0.09 |
HLA-B51 | 24 (60%) | 36 (38%) | 0.02 |
HLA-B27 | 3 (7.5%) | 9 (9.6%) | 0.68 |